Skip to the page

Data / Form D filings / Hilltop Biosciences Inc.

Hilltop Biosciences Inc.: Form D filings

Hilltop Biosciences Inc., a biotechnology company in Norwood, MA, filed 9 Form D notices with the SEC between 2019 and 2025. The latest, on March 31, 2025, reports $5.3 million sold of a $5.5 million offering to 73 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
320 Norwood Park, S, Norwood, MA, 02062
Phone
(617) 237-0636
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1782084

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 31, 2025Amendment$5,500,000$5,303,565$196,43573Nov 27, 2024sec.gov
Dec 12, 2024New notice$5,500,000$4,300,000$1,200,0006Nov 27, 2024sec.gov
Apr 3, 2023Amendment$1,000,000$723,524$276,47642Dec 20, 2022sec.gov
Feb 17, 2023Amendment$1,000,000$369,919$630,08135Dec 20, 2022sec.gov
Jan 3, 2023New notice$1,000,000$294,920$705,08031Dec 20, 2022sec.gov
Oct 4, 2021Amendment$1,430,000$866,345$563,65567Aug 18, 2021sec.gov
Aug 27, 2021New notice$1,430,000$784,320$645,68065Aug 18, 2021sec.gov
May 29, 2020New notice$450,000$149,746$300,25421May 14, 2020sec.gov
Jul 11, 2019New notice$1,000,000$750,854$249,14648Jul 2, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Mark WilliamsExecutive Officer, Director
Jessica McLearDirector
Alan WatsonDirector
Denise BeversDirector
Amanda DrobnisExecutive Officer, Director

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Mar 31, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Hilltop Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.